Farah Chali

791 total citations
16 papers, 580 citations indexed

About

Farah Chali is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Farah Chali has authored 16 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Surgery. Recurrent topics in Farah Chali's work include Neurogenetic and Muscular Disorders Research (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Farah Chali is often cited by papers focused on Neurogenetic and Muscular Disorders Research (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Farah Chali collaborates with scholars based in France, Germany and United States. Farah Chali's co-authors include Richard Miles, Giampaolo Milior, Mélanie Morin‐Brureau, Caroline Le Duigou, Etienne Savary, Nathalie Cartier, Fathia Djelti, Patrick Aubourg, Vincent Navarro and Catherine Marquer and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Brain.

In The Last Decade

Farah Chali

15 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farah Chali France 13 260 161 139 114 113 16 580
Fábio Rogério Brazil 16 254 1.0× 129 0.8× 50 0.4× 84 0.7× 62 0.5× 58 594
Barbara Noli Italy 17 221 0.8× 152 0.9× 55 0.4× 175 1.5× 70 0.6× 30 617
Kalicharan Patra Sweden 13 312 1.2× 301 1.9× 46 0.3× 141 1.2× 44 0.4× 22 705
André F. Batista Brazil 7 238 0.9× 119 0.7× 51 0.4× 356 3.1× 32 0.3× 9 690
Dione Kobayashi United States 14 450 1.7× 160 1.0× 151 1.1× 454 4.0× 253 2.2× 17 940
Céline Vermeiren Belgium 10 178 0.7× 186 1.2× 25 0.2× 141 1.2× 35 0.3× 14 461
Eleni Polyzoidou Greece 10 243 0.9× 140 0.9× 34 0.2× 111 1.0× 135 1.2× 15 636
Shiyong Liu China 18 344 1.3× 305 1.9× 24 0.2× 147 1.3× 40 0.4× 61 885
Ching‐Pang Chang Taiwan 14 430 1.7× 256 1.6× 51 0.4× 110 1.0× 19 0.2× 19 756
Christine R. Swanson United States 11 281 1.1× 186 1.2× 46 0.3× 150 1.3× 20 0.2× 12 601

Countries citing papers authored by Farah Chali

Since Specialization
Citations

This map shows the geographic impact of Farah Chali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farah Chali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farah Chali more than expected).

Fields of papers citing papers by Farah Chali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farah Chali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farah Chali. The network helps show where Farah Chali may publish in the future.

Co-authorship network of co-authors of Farah Chali

This figure shows the co-authorship network connecting the top 25 collaborators of Farah Chali. A scholar is included among the top collaborators of Farah Chali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farah Chali. Farah Chali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chali, Farah, Véronique Blouin, Wilfred F.A. den Dunnen, et al.. (2025). Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington’s disease. Acta Neuropathologica Communications. 13(1). 184–184.
2.
Nunes, Maria João, Andreia Neves Carvalho, Miguel Moutinho, et al.. (2023). Cholesterol redistribution triggered by CYP46A1 gene therapy improves major hallmarks of Niemann-Pick type C disease but is not sufficient to halt neurodegeneration. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(3). 166993–166993. 1 indexed citations
3.
Milior, Giampaolo, Mélanie Morin‐Brureau, Farah Chali, et al.. (2020). Distinct P2Y Receptors Mediate Extension and Retraction of Microglial Processes in Epileptic and Peritumoral Human Tissue. Journal of Neuroscience. 40(7). 1373–1388. 45 indexed citations
4.
D’Amico, Domenico, Jean Bastin, Farah Chali, et al.. (2019). Low-Intensity Running and High-Intensity Swimming Exercises Differentially Improve Energy Metabolism in Mice With Mild Spinal Muscular Atrophy. Frontiers in Physiology. 10. 1258–1258. 18 indexed citations
5.
Chali, Farah, Giampaolo Milior, Serge Marty, et al.. (2019). Lipid markers and related transcripts during excitotoxic neurodegeneration in kainate‐treated mice. European Journal of Neuroscience. 50(1). 1759–1778. 16 indexed citations
6.
Milior, Giampaolo, et al.. (2019). Transcriptomics and Live Imaging to Define Functional Phenotypes of Microglia in Pathological Human Tissue. Methods in molecular biology. 2034. 325–336. 4 indexed citations
7.
Duigou, Caroline Le, Etienne Savary, Mélanie Morin‐Brureau, et al.. (2018). Imaging pathological activities of human brain tissue in organotypic culture. Journal of Neuroscience Methods. 298. 33–44. 25 indexed citations
8.
Morin‐Brureau, Mélanie, Giampaolo Milior, Farah Chali, et al.. (2018). Microglial phenotypes in the human epileptic temporal lobe. Brain. 141(12). 3343–3360. 95 indexed citations
9.
Chali, Farah, Céline Desseille, Évelyne Benoit, et al.. (2016). Long‐term exercise‐specific neuroprotection in spinal muscular atrophy‐like mice. The Journal of Physiology. 594(7). 1931–1952. 26 indexed citations
10.
Djelti, Fathia, Jérôme Braudeau, Eloïse Hudry, et al.. (2015). CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer’s disease. Brain. 138(8). 2383–2398. 171 indexed citations
11.
Biondi, Olivier, Julien Branchu, L. Bertin, et al.. (2015). IGF-1R Reduction Triggers Neuroprotective Signaling Pathways in Spinal Muscular Atrophy Mice. Journal of Neuroscience. 35(34). 12063–12079. 39 indexed citations
12.
Chali, Farah, Fathia Djelti, Emmanuel Eugène, et al.. (2015). Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus. European Journal of Neuroscience. 41(10). 1345–1355. 26 indexed citations
13.
M’Dahoma, Saïd, S. Bourgoin, Valérie Kayser, et al.. (2014). Spinal Cord Transection-Induced Allodynia in Rats – Behavioral, Physiopathological and Pharmacological Characterization. PLoS ONE. 9(7). e102027–e102027. 33 indexed citations
14.
15.
Biondi, Olivier, Philippe Lopes, Céline Desseille, et al.. (2012). Physical exercise reduces cardiac defects in type 2 spinal muscular atrophy‐like mice. The Journal of Physiology. 590(22). 5907–5925. 13 indexed citations
16.
Fabre, Véronique, Farah Chali, D. Orsal, et al.. (2010). The deletion of the microtubule‐associated STOP protein affects the serotonergic mouse brain network. Journal of Neurochemistry. 115(6). 1579–1594. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026